News

Deal Announcements

Guardant Health Gets Venture Capital Funding

Thursday, February 13, 2014 5:55:00 AM PDT | VentureDeal
   Redwood City, CA  --  Sequencing company Guardant Health has secured Series A venture capital investment.

Guardant has developed technology that enables researchers to sequence cancer from a blood test rather than a biopsy.

Investors in the round included Sequoia Capital.

Proceeds purposes were not disclosed.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1